In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross- immunity against human visceral & cutaneous leishmaniasis: An Immunoinformatics-based approach [PDF]
Mainak Bhattacharjee +2 more
openalex +1 more source
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [PDF]
Previous studies demonstrated safety, immunogenicity and efficacy of DNA/modified vaccinia virus Ankara (MVA) prime/boost vaccines expressing tryparedoxin peroxidase (TRYP) and Leishmania homologue of the mammalian receptor for activated C kinase (LACK ...
Alcami, Antonio +7 more
core +1 more source
Leishmaniasis is a geographically widespread severe disease, with an increasing incidence of two million cases per year and 350 million people from 88 countries at risk. The causative agents are species of Leishmania, a protozoan flagellate.
Ayala, Francisco J +15 more
core +2 more sources
PO-0170 Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis: A Case Report [PDF]
Şit Uçar +3 more
openalex +1 more source
Leishmanioses are widespread in 88 countries of the tropical and subtropical zone, including regions of the Mediterranean Sea basin of Southern Europe. Actually, approximately 350 million of people live in Leishmania endemic areas and about 12 million of individuals are infected.
Jerzy, Stefaniak +3 more
openaire +1 more source
An effectiveness of Insecticide spray in the control of visceral leishmaniasis in Nepal
R. W. Ashford +3 more
openalex +2 more sources
Immunity and immunosuppression in experimental visceral leishmaniasis
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj
A Leishmania infantum FML-ELISA for the Detection of Symptomatic and Asymptomatic Canine Visceral Leishmaniasis in an Endemic Area of Iran [PDF]
Background: Visceral leishmaniasis (VL) is caused by Leishmania infantum in Mediterranean basin and is an endemic disease in some parts of Iran. Canines are the main reservoirs of VL in most of the endemic areas.
بهلولی, شهاب +6 more
core

